Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
Abdessamad El Kaoutari, Nicolás A. Fraunhoffer, Owen Hoare, et al.
EBioMedicine (2021) Vol. 66, pp. 103332-103332
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Small molecule metabolites: discovery of biomarkers and therapeutic targets
Shi Qiu, Ying Cai, Hong Yao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 331
Patient-derived xenograft models in cancer therapy: technologies and applications
Yihan Liu, Wantao Wu, Changjing Cai, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 167
Impact of cancer metabolism on therapy resistance – Clinical implications
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100797-100797
Open Access | Times Cited: 84
Illuminating the immunological landscape: mitochondrial gene defects in pancreatic cancer through a multiomics lens
Hao Chi, Lanqian Su, Yalan Yan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)
Michal Zuzčák, Ján Trnka
International Journal of Oncology (2022) Vol. 61, Iss. 2
Open Access | Times Cited: 24
Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study
Rui Zhao, Shuai Ren, Changyin Li, et al.
Cancer Medicine (2022) Vol. 12, Iss. 4, pp. 5158-5171
Open Access | Times Cited: 22
Single-Cell Lipidomics Using Analytical Flow LC-MS Characterizes the Response to Chemotherapy in Cultured Pancreatic Cancer Cells
Kyle D. G. Saunders, Johanna von Gerichten, Holly-May Lewis, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 39, pp. 14727-14735
Open Access | Times Cited: 15
The relationship between tumor metabolism and 5-fluorouracil resistance
Jingyi Hu, Anqi Li, Yueyang Guo, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115902-115902
Closed Access | Times Cited: 13
When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): Progress, potential, and perspective
Zhiqiang Zhang, Chaohui Bao, Jiang Lu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 10
Understanding the Conundrum of Pancreatic Cancer in the Omics Sciences Era
Alberto Nicoletti, Mattia Paratore, Federica Vitale, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7623-7623
Open Access | Times Cited: 3
iMSEA: A Novel Metabolite Set Enrichment Analysis Strategy to Decipher Drug Interactions
Yongpei Wang, Xingxing Liu, Liheng Dong, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 15, pp. 6203-6211
Closed Access | Times Cited: 9
Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
Gabriela Reyes‐Castellanos, Nadine Abdel Hadi, Scarlett Gallardo-Arriaga, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106899-106899
Open Access | Times Cited: 9
Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review
Gloria Perazzoli, Olga María García-Valdeavero, Mercedes Peña, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 872-872
Open Access | Times Cited: 9
The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer
Aubrey L. Miller, Patrick L. Garcia, Samuel C. Fehling, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3470-3470
Open Access | Times Cited: 21
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, et al.
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 13
Uncovering metabolic signatures in cancer-derived exosomes: LC-MS/MS and NMR profiling
Nandini Bajaj, Deepika Sharma
Nanoscale (2024)
Closed Access | Times Cited: 2
Targeting aberrant amino acid metabolism for pancreatic cancer therapy: Opportunities for nanoparticles
Xinlong Zang, Ke Lei, Jia Wang, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155071-155071
Closed Access | Times Cited: 1
Unveiling the intricate causal nexus between pancreatic cancer and peripheral metabolites through a comprehensive bidirectional two-sample Mendelian randomization analysis
Rong Sun, Haoyu Xu, Feng Liu, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 4
Drug Targeting of Acyltransferases in the Triacylglyceride and 1-O-AcylCeramide Biosynthetic Pathways
María José Hernandez‐Corbacho, Daniel Canals
Molecular Pharmacology (2023) Vol. 105, Iss. 3, pp. 166-178
Closed Access | Times Cited: 4
Tumor heterogeneity: An oncogenic driver of PDAC progression and therapy resistance under stress conditions
Antonio Palma, Vignesh Vudatha, Maria Leonor Peixoto, et al.
Advances in cancer research (2023), pp. 203-249
Closed Access | Times Cited: 3
Integrative transcriptomic analysis identifies a novel gene signature to predict prognosis of pancreatic cancer in different subtypes
Cordelia Y. Li, Kimal Rajapakshe, Anirban Maitra
Pancreatology (2022) Vol. 22, Iss. 7, pp. 965-972
Closed Access | Times Cited: 4
Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
Pochung Jordan Chou, Md Shahid Sarwar, Lujing Wang, et al.
Cancer Prevention Research (2023) Vol. 16, Iss. 6, pp. 321-332
Open Access | Times Cited: 2
Single-cell RNA sequencing analysis revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer
Haiyang Du, Si Gao, Jiqing Si, et al.
Clinics and Research in Hepatology and Gastroenterology (2023) Vol. 47, Iss. 8, pp. 102200-102200
Open Access | Times Cited: 2
Interrogating Matrix Stiffness and Metabolomics in Pancreatic Ductal Carcinoma Using an Openable Microfluidic Tumor-on-a-Chip
Michael D. Mohan, Neda Latifi, Robert Flick, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access
Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer
Manoj Amrutkar, Sander Johannes Thorbjørnsen Guttorm, Anette Vefferstad Finstadsveen, et al.
Molecular Oncology (2024)
Open Access
Page 1 - Next Page

Scroll to top